{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:05:52Z","timestamp":1787961952659,"version":"build-2784847793"},"reference-count":244,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004920","name":"Royan Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtn.2025.102682","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:34:45Z","timestamp":1755243285000},"page":"102682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Progress and prospect of minicircle as a minimized non-viral DNA vector in gene therapy and regenerative medicine"],"prefix":"10.1016","volume":"36","author":[{"given":"Pegah","family":"Chanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeimeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-3099","authenticated-orcid":false,"given":"Kianoush","family":"Dormiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Shokatian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh Sanei","family":"Ata-abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102682_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene Therapy","volume":"381","author":"High","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib2","series-title":"Cell-Based Therapy for Retinal Degenerative Disease","article-title":"Cell and Gene Therapy","author":"Rao","year":"2014"},{"key":"10.1016\/j.omtn.2025.102682_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","article-title":"Nonviral gene delivery: principle, limitations, and recent progress","volume":"11","author":"Al-Dosari","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.omtn.2025.102682_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fgene.2019.00868","article-title":"Development and clinical translation of approved gene therapy products for genetic disorders","volume":"10","author":"Shahryari","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/156652311798192798","article-title":"Building mosaics of therapeutic plasmid gene vectors","volume":"11","author":"Tolmachov","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib6","series-title":"Gene Therapy of Cancer: Methods and Protocols","first-page":"87","article-title":"Use of Minicircle Plasmids for Gene Therapy","author":"Mayrhofer","year":"2009"},{"key":"10.1016\/j.omtn.2025.102682_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/genes8020065","article-title":"Advances in non-viral DNA vectors for gene therapy","volume":"8","author":"Hardee","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2025.102682_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.aaf4770","article-title":"Paying for future success in gene therapy","volume":"352","author":"Orkin","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102682_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/10409238.2017.1304354","article-title":"Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side","volume":"52","author":"Hudecek","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102682_bib10","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1002\/cpmo.58","article-title":"Viral vectors for gene transfer","volume":"8","author":"Chen","year":"2018","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.omtn.2025.102682_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.omtn.2025.102682_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymthe.2006.01.003","article-title":"Adenovirus type 5 interactions with human blood cells may compromise systemic delivery","volume":"14","author":"Lyons","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib14","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/genes13081370","article-title":"Appraisal for the potential of viral and nonviral vectors in gene therapy: A review","volume":"13","author":"Butt","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2025.102682_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12033-008-9046-7","article-title":"Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA","volume":"39","author":"Mairhofer","year":"2008","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102682_bib16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1089\/hum.2017.159","article-title":"Plasmid DNA manufacturing for indirect and direct clinical applications","volume":"28","author":"Schmeer","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3721","article-title":"Gene therapy clinical trials worldwide to 2023\u2014an update","volume":"26","author":"Ginn","year":"2024","journal-title":"J. Gene Med."},{"key":"10.1016\/j.omtn.2025.102682_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/gt.2008.183","article-title":"Progress and prospects: the design and production of plasmid vectors","volume":"16","author":"Gill","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymeth.2009.07.001","article-title":"Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors","volume":"49","author":"Izsv\u00e1k","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.omtn.2025.102682_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712598.2015.996544","article-title":"Minicircle DNA vectors for gene therapy: advances and applications","volume":"15","author":"Gaspar","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib21","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U","article-title":"Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments","volume":"32","author":"Ahmad-Nejad","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2025.102682_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.gt.3302231","article-title":"Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo","volume":"11","author":"Chen","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib23","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/mt.2012.65","article-title":"The extragenic spacer length between the 5\u2032 and 3\u2032 ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors","volume":"20","author":"Lu","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ymthe.2017.03.003","article-title":"Sequence-modified antibiotic resistance genes provide sustained plasmid-mediated transgene expression in mammals","volume":"25","author":"Lu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib25","series-title":"Minicircle and Miniplasmid Dna Vectors: The Future of Non-viral and Viral Gene Transfer","first-page":"7","author":"Cranenburgh, R","year":"2013"},{"key":"10.1016\/j.omtn.2025.102682_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.tibtech.2013.06.001","article-title":"Marker-free plasmids for biotechnological applications\u2013implications and perspectives","volume":"31","author":"Oliveira","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2025.102682_bib27","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.18609\/cgti.2020.163","article-title":"Improving therapeutic potential of non-viral minimized DNA vectors","volume":"6","author":"Ar\u00e9valo-Soliz","year":"2020","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omtn.2025.102682_bib28","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1088\/0953-8984\/18\/14\/S01","article-title":"Exploring writhe in supercoiled minicircle DNA","volume":"18","author":"Fogg","year":"2006","journal-title":"J. Phys. Condens. Matter"},{"key":"10.1016\/j.omtn.2025.102682_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jmedgenet-2018-105405","article-title":"Bacteria-free minicircle DNA system to generate integration-free CAR-T cells","volume":"56","author":"Cheng","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.18609\/cgti.2017.020","article-title":"Minicircles: Next-generation gene vectors","volume":"3","author":"Shankar","year":"2017","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omtn.2025.102682_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11033-015-3864-z","article-title":"Construction of a new minicircle DNA carrying an enhanced green florescent protein reporter gene for efficient expression into mammalian cell lines","volume":"42","author":"Sanei Ata-Abadi","year":"2015","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib32","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nbt.1708","article-title":"A robust system for production of minicircle DNA vectors","volume":"28","author":"Kay","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102682_bib33","series-title":"Site-Specific Recombinases: Methods and Protocols","first-page":"325","article-title":"Production of Minicircle DNA Vectors Using Site-Specific Recombinases","author":"Ata-abadi","year":"2017"},{"key":"10.1016\/j.omtn.2025.102682_bib34","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/hum.2017.123","article-title":"Minicircle versus plasmid DNA delivery by receptor-targeted polyplexes","volume":"28","author":"Levacic","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120830","article-title":"An advanced method for the small-scale production of high-quality minicircle DNA","volume":"605","author":"Mitdank","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2025.102682_bib36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/biomedicines10050990","article-title":"Maximization of the Minicircle DNA Vaccine Production Expressing SARS-CoV-2 RBD","volume":"10","author":"Ventura","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtn.2025.102682_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102275","article-title":"Minicircle DNA vectors: A breakthrough in non-viral delivery of CRISPR base editors?","volume":"35","author":"Kanada","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102682_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167537","article-title":"Effects of circular DNA length on transfection efficiency by electroporation into HeLa cells","volume":"11","author":"Hornstein","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102682_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/ijms18040819","article-title":"Minicircle mediated gene delivery to canine and equine mesenchymal stem cells","volume":"18","author":"Tidd","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102682_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.67","article-title":"Micro-minicircle gene therapy: Implications of size on fermentation, complexation, shearing resistance, and expression","volume":"3","author":"Stenler","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102682_bib41","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11033-019-04624-x","article-title":"Episomal minicircles persist in periods of transcriptional inactivity and can be transmitted through somatic cell nuclear transfer into bovine embryos","volume":"46","author":"Wagner","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2015.12.012","article-title":"Non-viral gene therapy: Gains and challenges of non-invasive administration methods","volume":"240","author":"Foldvari","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2025.102682_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nmeth.1426","article-title":"A nonviral minicircle vector for deriving human iPS cells","volume":"7","author":"Jia","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2025.102682_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1525-0016(03)00168-0","article-title":"Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo","volume":"8","author":"Chen","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.omtn.2017.04.013","article-title":"Low-dose gene therapy for murine PKU using episomal naked DNA vectors expressing PAH from its endogenous liver promoter","volume":"7","author":"Grisch-Chan","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102682_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/srep23125","article-title":"Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer","volume":"6","author":"Munye","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib47","article-title":"Coordinating the in vivo processes for minicircle production-a novel approach to large scale manufacturing","author":"Mayrhofer","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102682_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-4939-0410-5_14","article-title":"Pharmaceutical grade large-scale plasmid DNA manufacturing process","volume":"1143","author":"Schmeer","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102682_bib49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/genes15030261","article-title":"Antibiotic-Free Gene Vectors: A 25-Year Journey to Clinical Trials","volume":"15","author":"Marie","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2025.102682_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.62","article-title":"Increasing the minicircle DNA purity using an enhanced triplex DNA technology to eliminate DNA contaminants","volume":"2","author":"Hou","year":"2015","journal-title":"Mol. Therapy Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102682_bib52","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.tibtech.2020.04.008","article-title":"Minicircle DNA: the future for DNA-based vectors?","volume":"38","author":"Almeida","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2025.102682_bib53","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1007\/s00253-016-7565-x","article-title":"Improvement of DNA minicircle production by optimization of the secondary structure of the 5\u2032-UTR of ParA resolvase","volume":"100","author":"\u0160im\u010d\u00edkov\u00e1","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102682_bib54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.seppur.2016.10.054","article-title":"Highly selective capture of minicircle DNA biopharmaceuticals by a novel zinc-histidine peptide conjugate","volume":"174","author":"Gaspar","year":"2017","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.omtn.2025.102682_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jchromb.2019.04.024","article-title":"Minicircle DNA purification: Performance of chromatographic monoliths bearing lysine and cadaverine ligands","volume":"1118","author":"Almeida","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.omtn.2025.102682_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2019.460444","article-title":"The use of size-exclusion chromatography in the isolation of supercoiled minicircle DNA from Escherichia coli lysate","volume":"1609","author":"Almeida","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.omtn.2025.102682_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hgtb.2018.046","article-title":"Production and purification of supercoiled minicircles by a combination of in vitro endonuclease nicking and hydrophobic interaction chromatography","volume":"29","author":"Alves","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtn.2025.102682_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fceng.2020.612594","article-title":"Minicircle biopharmaceuticals\u2013an overview of purification strategies","volume":"2","author":"Alves","year":"2021","journal-title":"Front. Chem. Eng."},{"key":"10.1016\/j.omtn.2025.102682_bib59","article-title":"Plasmid2MC: Efficient cell-free recombination of plasmids into high-purity minicircle DNA for use in genome editing applications","author":"Oliynyk","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102682_bib60","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.2147\/OTT.S247836","article-title":"Minicircle DNA-mediated CAR T cells targeting CD44 suppressed hepatocellular carcinoma both in vitro and in vivo","volume":"13","author":"Wang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib61","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1038\/s41467-019-11190-0","article-title":"Highly branched poly (\u03b2-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102682_bib62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12860-020-00250-9","article-title":"Minicircle DNA vector expressing interferon-lambda-3 inhibits hepatitis B virus replication and expression in hepatocyte-derived cell line","volume":"21","author":"Guo","year":"2020","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102682_bib63","article-title":"Harnessing Extracellular Vesicles for Stabilized and Functional IL-10 Delivery in Macrophage Immunomodulation","author":"Saleh","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102682_bib64","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/hv.28077","article-title":"Safety and efficacy of DNA vaccines: plasmids vs. minicircles","volume":"10","author":"Stenler","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omtn.2025.102682_bib65","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4939-2727-2_18","article-title":"Minicircle: next generation DNA vectors for vaccination","volume":"1317","author":"Schleef","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102682_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.omtm.2020.10.004","article-title":"Clinical development of gene therapies: the first three decades and counting","volume":"19","author":"Lapteva","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102682_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fbioe.2019.00131","article-title":"At the intersection of biomaterials and gene therapy: progress in non-viral delivery of nucleic acids","volume":"7","author":"Uludag","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102682_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199171","article-title":"Exploring the role of NCCR variation on JC polyomavirus expression from dual reporter minicircles","volume":"13","author":"L\u2019Honneur","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102682_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.omto.2021.01.007","article-title":"A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omtn.2025.102682_bib70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3389\/fimmu.2018.01339","article-title":"Kruppel-like factor 4 positively regulates autoimmune arthritis in mouse models and rheumatoid arthritis in patients via modulating cell survival and inflammation factors of fibroblast-like synoviocyte","volume":"9","author":"Choi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2025.102682_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","article-title":"MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-\u03baB-TNF\u03b1 pathway","volume":"70","author":"Zhang","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102682_bib72","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1080\/21645515.2017.1338546","article-title":"Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses","volume":"13","author":"Stenler","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omtn.2025.102682_bib73","doi-asserted-by":"crossref","first-page":"e00407-19","DOI":"10.1128\/AEM.00407-19","article-title":"A novel Cre recombinase-mediated in vivo minicircle DNA (CRIM) vaccine provides partial protection against Newcastle disease virus","volume":"85","author":"Jiang","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.omtn.2025.102682_bib74","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jhep.2017.02.004","article-title":"HBVcircle: a novel tool to investigate hepatitis B virus covalently closed circular DNA","volume":"66","author":"Yan","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102682_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.gene.2018.11.069","article-title":"An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells","volume":"686","author":"Haridhasapavalan","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2025.102682_bib76","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/pharmaceutics13050736","article-title":"Minicircles for investigating and treating arthritic diseases","volume":"13","author":"Rim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2025.102682_bib77","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.omto.2022.02.014","article-title":"Anticancer effects of a single intramuscular dose of a minicircle DNA vector expressing anti-CD3\/CD20 in a xenograft mouse model","volume":"24","author":"Pang","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omtn.2025.102682_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911673","article-title":"Minicircle delivery to the neural retina as a gene therapy approach","volume":"23","author":"Staurenghi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102682_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102248","article-title":"Evaluation of DNA minicircles for delivery of adenine and cytosine base editors using activatable gene on \u201cGO\u201d reporter imaging systems","volume":"35","author":"Evans","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102682_bib80","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3390\/genes13122363","article-title":"A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells","volume":"13","author":"Jurlina","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2025.102682_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PLAS-0022-2014","article-title":"Plasmid Biopharmaceuticals","volume":"2","author":"Prazeres","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.omtn.2025.102682_bib82","doi-asserted-by":"crossref","first-page":"19284","DOI":"10.1021\/acsami.6b04412","article-title":"Synthesis of amphiphilic poly (\u03b2-amino ester) for efficiently minicircle DNA delivery in vivo","volume":"8","author":"Zhao","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.omtn.2025.102682_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146289","article-title":"Reactivation of \u03b3-globin expression using a minicircle DNA system to treat \u03b2-thalassemia","volume":"820","author":"Ma","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2025.102682_bib84","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nano.2018.12.018","article-title":"Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders","volume":"17","author":"Gallego","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.omtn.2025.102682_bib85","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ymthe.2020.01.023","article-title":"Repair of retinal degeneration following ex vivo minicircle DNA gene therapy and transplantation of corrected photoreceptor progenitors","volume":"28","author":"Barnea-Cramer","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib86","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/term.3049","article-title":"Minicircle-based GCP-2 ex vivo gene therapy enhanced the reepithelialization and angiogenic capacity","volume":"14","author":"Han","year":"2020","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib87","doi-asserted-by":"crossref","first-page":"30661","DOI":"10.1021\/acsami.9b13135","article-title":"Efficient and robust highly branched poly (\u03b2-amino ester)\/minicircle COL7A1 polymeric nanoparticles for gene delivery to recessive dystrophic epidermolysis bullosa keratinocytes","volume":"11","author":"Zeng","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.omtn.2025.102682_bib88","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/acs.nanolett.8b04098","article-title":"Manipulation of transgene expression in fibroblast cells by a multifunctional linear-branched hybrid poly (\u03b2-amino ester) synthesized through an oligomer combination approach","volume":"19","author":"Zeng","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2025.102682_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312774","article-title":"Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102682_bib90","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","article-title":"Systemic exosomal delivery of shRNA minicircles prevents parkinsonian pathology","volume":"27","author":"Izco","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib91","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2016.12.016","article-title":"MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis","volume":"66","author":"Wu","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102682_bib92","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000499863","article-title":"Therapeutic challenge of minicircle vector encoding klotho in animal model","volume":"49","author":"Shin","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.omtn.2025.102682_bib93","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/hum.2019.014","article-title":"Treatment of cystathionine \u03b2-synthase deficiency in mice using a minicircle-based naked DNA vector","volume":"30","author":"Lee","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib94","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/v7092854","article-title":"Anti-HBV drugs: progress, unmet needs, and new hope","volume":"7","author":"Kang","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2025.102682_bib95","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1096\/fj.201900833R","article-title":"Host cell in vivo production of the synthetic drug anti\u2013CD25\/IL-10 using minicircle vector","volume":"33","author":"Lim","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2025.102682_bib96","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3904\/kjim.2021.299","article-title":"Therapeutic effect of multiple functional minicircle vector encoding anti-CD25\/IL-10\/CXCR3 in allograft rejection model","volume":"37","author":"Lim","year":"2022","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib97","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2025.102682_bib98","series-title":"Molecular Hematology.","first-page":"1","article-title":"Beginnings: the molecular pathology of hemoglobin.","author":"Weatherall","year":"2010"},{"key":"10.1016\/j.omtn.2025.102682_bib99","series-title":"The Thalassaemia Syndromes","author":"Weatherall","year":"2001"},{"key":"10.1016\/j.omtn.2025.102682_bib100","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","article-title":"\u03b2-Thalassemia","volume":"353","author":"Rund","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib101","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib102","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","article-title":"Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102682_bib103","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41588-019-0568-7","article-title":"Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation","volume":"52","author":"Basak","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib104","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/asheducation-2011.1.459","article-title":"Targeted therapeutic strategies for fetal hemoglobin induction","volume":"2011","author":"Sankaran","year":"2011","journal-title":"Hematology. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.omtn.2025.102682_bib105","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2012-10-408021","article-title":"Clinical experience with fetal hemoglobin induction therapy in patients with \u03b2-thalassemia","volume":"121","author":"Musallam","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2025.102682_bib106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib107","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/bloodadvances.2019000820","article-title":"Genome editing of HBG1 and HBG2 to induce fetal hemoglobin","volume":"3","author":"M\u00e9tais","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtn.2025.102682_bib108","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102682_bib109","article-title":"A review of secondary photoreceptor degenerations in systemic disease","volume":"5","author":"Mysore","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.preteyeres.2012.09.001","article-title":"Clinical applications of retinal gene therapy","volume":"32","author":"Lipinski","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2025.102682_bib111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trsl.2012.12.007","article-title":"Gene therapy for retinal disease","volume":"161","author":"McClements","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.omtn.2025.102682_bib112","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41586-018-0425-3","article-title":"Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas","volume":"560","author":"Yao","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102682_bib113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymthe.2004.09.022","article-title":"Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain","volume":"11","author":"Provost","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2025.102682_bib116","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1442-9071.2011.02649.x","article-title":"Non-viral retinal gene therapy: a review","volume":"40","author":"Issa","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.omtn.2025.102682_bib117","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acs.molpharmaceut.5b00422","article-title":"Protamine\/DNA\/niosome ternary nonviral vectors for gene delivery to the retina: the role of protamine","volume":"12","author":"Puras","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2025.102682_bib118","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2013.11.004","article-title":"A novel cationic niosome formulation for gene delivery to the retina","volume":"174","author":"Puras","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2025.102682_bib119","first-page":"GE01","article-title":"Non viral vectors in gene therapy-an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.omtn.2025.102682_bib120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.34.945","article-title":"Niosomes: a controlled and novel drug delivery system","volume":"34","author":"Rajera","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.omtn.2025.102682_bib121","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/j.biomaterials.2004.01.031","article-title":"Low toxicity of cationic lipid-based emulsion for gene transfer","volume":"25","author":"Choi","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2025.102682_bib122","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/msg.2001.111167","article-title":"Wound healing; biologic features and approaches to maximize healing trajectories","volume":"38","author":"Robson","year":"2001","journal-title":"Curr. Probl. Surg."},{"key":"10.1016\/j.omtn.2025.102682_bib123","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/wound.2012.0380","article-title":"Chemokines and their receptors are key players in the orchestra that regulates wound healing","volume":"2","author":"Martins-Green","year":"2013","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.omtn.2025.102682_bib124","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvs224","article-title":"Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model","volume":"95","author":"Kim","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omtn.2025.102682_bib125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.31729\/jnma.3791","article-title":"Dystrophic epidermolysis bullosa","volume":"56","author":"Yadav","year":"2018","journal-title":"JNMA. J. Nepal Med. Assoc."},{"key":"10.1016\/j.omtn.2025.102682_bib126","first-page":"41","article-title":"Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies","volume":"8","author":"Soro","year":"2015","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.omtn.2025.102682_bib127","doi-asserted-by":"crossref","first-page":"34218","DOI":"10.1021\/acsami.6b12078","article-title":"Development of branched poly (5-amino-1-pentanol-co-1, 4-butanediol diacrylate) with high gene transfection potency across diverse cell types","volume":"8","author":"Zhou","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.omtn.2025.102682_bib128","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib129","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1016\/j.vaccine.2009.05.022","article-title":"Skin-specific promoters for genetic immunisation by DNA electroporation","volume":"27","author":"Vandermeulen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102682_bib130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbrc.2010.09.131","article-title":"Targeted methylation of CMV and E1A viral promoters","volume":"402","author":"Hsu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2025.102682_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144958","article-title":"Lack of methylation on transgene leads to high level and persistent transgene expression in induced pluripotent stem cells","volume":"758","author":"Alhaji","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2025.102682_bib132","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson's disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102682_bib133","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2017.06.018","article-title":"Clinical approaches to the development of a neuroprotective therapy for PD","volume":"298","author":"Olanow","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2025.102682_bib134","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting \u03b1-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2025.102682_bib135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtn.2025.102682_bib136","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson's disease linked to pathological \u03b1-synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2025.102682_bib138","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102682_bib139","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jhep.2020.08.003","article-title":"Gene therapies targeting the liver","volume":"74","author":"Cozmescu","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102682_bib140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102682_bib141","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2025.102682_bib142","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pharmtox-010716-104944","article-title":"PCSK9: regulation and target for drug development for dyslipidemia","volume":"57","author":"Burke","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.omtn.2025.102682_bib143","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.omtn.2025.102682_bib144","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOL.0000000000000420","article-title":"MicroRNAs and lipid metabolism","volume":"28","author":"Aryal","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.omtn.2025.102682_bib145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41580-021-00354-w","article-title":"MicroRNA-mediated regulation of glucose and lipid metabolism","volume":"22","author":"Agbu","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102682_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.716213","article-title":"Roles of micrornas in glucose and lipid metabolism in the heart","volume":"8","author":"Du","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib147","series-title":"Endocr. Abstracts","article-title":"Pathogenesis of fatty liver disease","author":"Postic","year":"2012"},{"key":"10.1016\/j.omtn.2025.102682_bib148","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferre","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.omtn.2025.102682_bib149","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5414\/CN108970","article-title":"Serum klotho levels in acute kidney injury","volume":"87","author":"Seibert","year":"2017","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.omtn.2025.102682_bib150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2025.102682_bib151","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia\u2013reperfusion injury and its replacement is protective","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2025.102682_bib152","doi-asserted-by":"crossref","first-page":"e2972","DOI":"10.1038\/cddis.2017.365","article-title":"Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K\/AKT pathway during tacrolimus-induced oxidative stress","volume":"8","author":"Lim","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2025.102682_bib153","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.celrep.2017.07.024","article-title":"Peripheral elevation of a klotho fragment enhances brain function and resilience in young, aging, and \u03b1-synuclein transgenic mice","volume":"20","author":"Leon","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib154","series-title":"Hypermethioninemias of Genetic and Non-genetic Origin: A Review, American Journal of Medical Genetics Part C: Seminars in Medical Genetics","first-page":"3","author":"Mudd","year":"2011"},{"key":"10.1016\/j.omtn.2025.102682_bib155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","article-title":"Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency","volume":"40","author":"Morris","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2025.102682_bib156","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","article-title":"Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall","volume":"173","author":"Balint","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.omtn.2025.102682_bib157","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jcp-2021-208029","article-title":"Homocystinuria diagnosis and management: it is not all classical","volume":"75","author":"Gerrard","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.omtn.2025.102682_bib158","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/hmg\/ddi224","article-title":"Expression of mutant human cystathionine \u03b2-synthase rescues neonatal lethality but not homocystinuria in a mouse model","volume":"14","author":"Wang","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102682_bib159","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/344271","article-title":"Effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis","volume":"35","author":"Fisman","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102682_bib160","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.omtn.2025.102682_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-\u03bb) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2025.102682_bib163","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1038\/srep05961","article-title":"A new strategy to deliver synthetic protein drugs: self-reproducible biologics using minicircles","volume":"4","author":"Yi","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib164","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1038\/srep06935","article-title":"Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector","volume":"4","author":"Rim","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib165","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015552","article-title":"Regulatory T-cell therapy in transplantation: moving to the clinic","volume":"3","author":"Tang","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib166","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nri1027","article-title":"Regulatory T cells in transplantation tolerance","volume":"3","author":"Wood","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2025.102682_bib167","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4049\/jimmunol.170.3.1556","article-title":"Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft","volume":"170","author":"Jiankuo","year":"2003","journal-title":"J. Immun"},{"key":"10.1016\/j.omtn.2025.102682_bib168","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1073\/pnas.1508520112","article-title":"Regenerative medicine: Current therapies and future directions","volume":"112","author":"Mao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102682_bib169","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800412","article-title":"4D biofabrication: materials, methods, and applications","volume":"7","author":"Ionov","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.omtn.2025.102682_bib170","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1098\/rsif.2010.0348.focus","article-title":"Regenerative medicine: the emergence of an industry","volume":"7","author":"Nerem","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.omtn.2025.102682_bib171","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6737345","article-title":"Adipose-derived stem cells for tissue engineering and regenerative medicine applications","volume":"2016","author":"Dai","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.omtn.2025.102682_bib172","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jconrel.2016.06.024","article-title":"Part I: Minicircle vector technology limits DNA size restrictions on ex vivo gene delivery using nanoparticle vectors: Overcoming a translational barrier in neural stem cell therapy","volume":"238","author":"Fernandes","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2025.102682_bib173","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2020.02.028","article-title":"Safe nanoengineering and incorporation of transplant populations in a neurosurgical grade biomaterial, DuraGen PlusTM, for protected cell therapy applications","volume":"321","author":"Finch","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2025.102682_bib174","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1039\/C7NR00811B","article-title":"A fusion of minicircle DNA and nanoparticle delivery technologies facilitates therapeutic genetic engineering of autologous canine olfactory mucosal cells","volume":"9","author":"Delaney","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.omtn.2025.102682_bib175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5966\/sctm.2016-0051","article-title":"Magnetic nanoparticle-based upregulation of B-cell lymphoma 2 enhances bone regeneration","volume":"6","author":"Brett","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib176","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1074\/jbc.M113.539825","article-title":"Involvement of angiopoietin-like 4 in matrix remodeling during chondrogenic differentiation of mesenchymal stem cells","volume":"289","author":"Mathieu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102682_bib177","doi-asserted-by":"crossref","first-page":"191","DOI":"10.22203\/eCM.v031a13","article-title":"Improved osteogenic vector for non-viral gene therapy","volume":"31","author":"Hacobian","year":"2016","journal-title":"Eur. Cell. Mater."},{"key":"10.1016\/j.omtn.2025.102682_bib178","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/cells9030582","article-title":"Chondrogenic differentiation from induced pluripotent stem cells using non-viral minicircle vectors","volume":"9","author":"Rim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2025.102682_bib179","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.3390\/ijms22169069","article-title":"Increased Potential of Bone Formation with the Intravenous Injection of a Parathyroid Hormone-Related Protein Minicircle DNA Vector","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102682_bib180","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41598-024-51957-0","article-title":"Effects of stepwise administration of osteoprotegerin and parathyroid hormone-related peptide DNA vectors on bone formation in ovariectomized rat model","volume":"14","author":"Eom","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib181","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13287-021-02245-5","article-title":"Gene engineered mesenchymal stem cells: greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury","volume":"12","author":"Florian","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib182","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1089\/hum.2018.154","article-title":"Engineering of human mesenchymal stem\/stromal cells with vascular endothelial growth factor\u2013encoding minicircles for angiogenic ex vivo gene therapy","volume":"30","author":"Serra","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3342","article-title":"Minicircle-based expression of vascular endothelial growth factor in mesenchymal stromal cells from diverse human tissues","volume":"23","author":"Serra","year":"2021","journal-title":"J. Gene Med."},{"key":"10.1016\/j.omtn.2025.102682_bib184","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1016\/j.biomaterials.2013.02.002","article-title":"Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel","volume":"34","author":"Mothe","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2025.102682_bib185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S1740925X04000213","article-title":"Differential fate of multipotent and lineage-restricted neural precursors following transplantation into the adult CNS","volume":"1","author":"Lepore","year":"2004","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.omtn.2025.102682_bib186","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/157488810790442778","article-title":"Cell based-gene delivery approaches for the treatment of spinal cord injury and neurodegenerative disorders","volume":"5","author":"Taha","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib187","first-page":"395","article-title":"SDF-1 overexpression by mesenchymal stem cells enhances GAP-43-positive axonal growth following spinal cord injury","volume":"35","author":"Stewart","year":"2017","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.omtn.2025.102682_bib188","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0896-6273(00)80905-8","article-title":"Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia","volume":"25","author":"Ram\u00f3n-Cueto","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2025.102682_bib189","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/1073858413514635","article-title":"Cell therapy for spinal cord injuries: what is really going on?","volume":"20","author":"Granger","year":"2014","journal-title":"Neuroscientist"},{"key":"10.1016\/j.omtn.2025.102682_bib190","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrn1955","article-title":"Therapeutic interventions after spinal cord injury","volume":"7","author":"Thuret","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.omtn.2025.102682_bib191","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/10790268.2008.11760720","article-title":"Novel combination strategies to repair the injured mammalian spinal cord","volume":"31","author":"Bunge","year":"2008","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.omtn.2025.102682_bib192","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.expneurol.2012.09.001","article-title":"BDNF: the career of a multifaceted neurotrophin in spinal cord injury","volume":"238","author":"Weishaupt","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2025.102682_bib193","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10495-015-1203-4","article-title":"Stem cell death and survival in heart regeneration and repair","volume":"21","author":"Abdelwahid","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.omtn.2025.102682_bib194","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/153857440503900401","article-title":"Angiogenesis, vasculogenesis, and induction of healing in chronic wounds","volume":"39","author":"Bauer","year":"2005","journal-title":"Vasc. Endovascular Surg."},{"key":"10.1016\/j.omtn.2025.102682_bib195","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5966\/sctm.2013-0035","article-title":"Enhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vector","volume":"2","author":"Hyun","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib196","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1093\/nar\/gkv688","article-title":"The transcription factors SOX9 and SOX5\/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis","volume":"43","author":"Liu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102682_bib197","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.biomaterials.2011.02.054","article-title":"Chondrogenesis of adipose stem cells in a porous PLGA scaffold impregnated with plasmid DNA containing SOX trio (SOX-5,-6 and-9) genes","volume":"32","author":"Im","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2025.102682_bib198","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1093\/emboj\/17.19.5718","article-title":"A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene","volume":"17","author":"Lefebvre","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2025.102682_bib199","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fendo.2017.00080","article-title":"Multiple roles of angiopoietin-like 4 in osteolytic disease","volume":"8","author":"Knowles","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.omtn.2025.102682_bib200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MOH.0000000000000580","article-title":"ANGPTL4, a multifunctional protein involved in metabolism and vascular homeostasis","volume":"27","author":"Fern\u00e1ndez-Hernando","year":"2020","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.omtn.2025.102682_bib201","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jbm.b.34383","article-title":"Dual functional nanoparticles containing SOX duo and ANGPT4 shRNA for osteoarthritis treatment","volume":"108","author":"Jeong","year":"2020","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.omtn.2025.102682_bib202","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118357","article-title":"Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration","volume":"96","author":"Hollander","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102682_bib203","doi-asserted-by":"crossref","first-page":"e162775","DOI":"10.1001\/jamasurg.2016.2775","article-title":"Epidemiology of fracture nonunion in 18 human bones","volume":"151","author":"Zura","year":"2016","journal-title":"JAMA Surg."},{"key":"10.1016\/j.omtn.2025.102682_bib204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/ten.teb.2009.0156","article-title":"Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures","volume":"16","author":"Pelled","year":"2010","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.omtn.2025.102682_bib205","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0020-1383(08)70007-X","article-title":"Use of bone morphogenetic proteins for treatment of non-unions and future perspectives","volume":"38","author":"Schmidmaier","year":"2007","journal-title":"Injury"},{"key":"10.1016\/j.omtn.2025.102682_bib206","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.injury.2011.03.046","article-title":"Treatment of long bone non-unions with polytherapy: indications and clinical results","volume":"42","author":"Calori","year":"2011","journal-title":"Injury"},{"key":"10.1016\/j.omtn.2025.102682_bib207","first-page":"549","article-title":"The controversy surrounding bone morphogenetic proteins in the spine: a review of current research","volume":"87","author":"Hustedt","year":"2014","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib208","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2106\/JBJS.L.01483","article-title":"Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis","volume":"95","author":"Carragee","year":"2013","journal-title":"JBJS"},{"key":"10.1016\/j.omtn.2025.102682_bib209","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/mthe.2000.0663","article-title":"Gene transfer approaches to the healing of bone and cartilage","volume":"6","author":"Lieberman","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib210","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1089\/ten.2006.0107","article-title":"Recent advances in gene delivery for structural bone allografts","volume":"13","author":"Awad","year":"2007","journal-title":"Tissue Eng."},{"key":"10.1016\/j.omtn.2025.102682_bib211","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1566523220666200427121350","article-title":"Evaluation of BMP-2 minicircle DNA for enhanced bone engineering and regeneration","volume":"20","author":"Zimmermann","year":"2020","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib212","doi-asserted-by":"crossref","first-page":"19172","DOI":"10.1073\/pnas.1210422109","article-title":"Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells","volume":"109","author":"Diekman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102682_bib213","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/ten.tea.2009.0398","article-title":"Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix","volume":"16","author":"Diekman","year":"2010","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.omtn.2025.102682_bib214","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/ten.tea.2009.0100","article-title":"Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells","volume":"16","author":"Solchaga","year":"2010","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.omtn.2025.102682_bib215","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3892\/mmr.2013.1423","article-title":"Effect of cell culture using chitosan membranes on stemness marker genes in mesenchymal stem cells","volume":"7","author":"Li","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib216","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/cell.2009.0086","article-title":"Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells","volume":"12","author":"Teramura","year":"2010","journal-title":"Cell. Reprogram."},{"key":"10.1016\/j.omtn.2025.102682_bib217","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/scd.2012.0127","article-title":"Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells","volume":"22","author":"Koyama","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.omtn.2025.102682_bib218","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1089\/ten.tea.2008.0132","article-title":"BMP-2 enhances TGF-\u03b23\u2013mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture","volume":"15","author":"Shen","year":"2009","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.omtn.2025.102682_bib219","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","article-title":"Pathophysiology of osteoporosis: new mechanistic insights","volume":"41","author":"Armas","year":"2012","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.omtn.2025.102682_bib220","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102682_bib221","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40618-014-0152-z","article-title":"Treatment of post-menopausal osteoporosis: beyond bisphosphonates","volume":"38","author":"Ishtiaq","year":"2015","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.omtn.2025.102682_bib222","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.maturitas.2016.12.003","article-title":"Abaloparatide: recombinant human PTHrP (1\u201334) anabolic therapy for osteoporosis","volume":"97","author":"Chew","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.omtn.2025.102682_bib223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2018.11.010","article-title":"New therapeutic targets for osteoporosis","volume":"120","author":"Anagnostis","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.omtn.2025.102682_bib224","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11914-017-0353-4","article-title":"Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy","volume":"15","author":"Leder","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.omtn.2025.102682_bib225","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcp.22902","article-title":"Comparison of the skeletal effects induced by daily administration of PTHrP (1\u201336) and PTHrP (107\u2013139) to ovariectomized mice","volume":"227","author":"de Castro","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.omtn.2025.102682_bib226","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12956","article-title":"Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis","volume":"54","author":"Jiang","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.omtn.2025.102682_bib227","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","article-title":"Acute respiratory distress in adults","volume":"2","author":"Ashbaugh","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2025.102682_bib228","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2025.102682_bib229","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00134-016-4321-8","article-title":"Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers","volume":"42","author":"Herridge","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.omtn.2025.102682_bib230","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1097\/CCM.0000000000003406","article-title":"Beyond low tidal volume ventilation: treatment adjuncts for severe respiratory failure in acute respiratory distress syndrome","volume":"46","author":"Fielding-Singh","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.omtn.2025.102682_bib231","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","article-title":"Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice","volume":"179","author":"Gupta","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102682_bib232","first-page":"122","article-title":"Cell-based therapies for the acute respiratory distress syndrome","volume":"20","author":"Maron-Gutierrez","year":"2014","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.omtn.2025.102682_bib233","first-page":"1","article-title":"Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies","volume":"10","author":"Noronha","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt119","article-title":"Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia","volume":"3","author":"Liew","year":"2012","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2025.102682_bib235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/bmb\/ldt031","article-title":"The angiogenic properties of mesenchymal stem\/stromal cells and their therapeutic potential","volume":"108","author":"Watt","year":"2013","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.omtn.2025.102682_bib236","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/term.79","article-title":"Human mesenchymal stem cells as a stable source of VEGF-producing cells","volume":"2","author":"Kagiwada","year":"2008","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib237","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib238","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.addr.2010.08.010","article-title":"Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery","volume":"62","author":"Porada","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2025.102682_bib239","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcyt.2013.10.014","article-title":"Microencapsulated VEGF gene\u2013modified umbilical cord mesenchymal stromal cells promote the vascularization of tissue-engineered dermis: an experimental study","volume":"16","author":"Han","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtn.2025.102682_bib240","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.53","article-title":"Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia","volume":"3","author":"Beegle","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102682_bib241","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1479-5876-11-138","article-title":"Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle","volume":"11","author":"Shevchenko","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102682_bib242","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2007.10.014","article-title":"Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapy","volume":"125","author":"Chang","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2025.102682_bib243","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4093\/dmj.2011.35.3.226","article-title":"Comparison of EGF with VEGF non-viral gene therapy for cutaneous wound healing of streptozotocin diabetic mice","volume":"35","author":"Ko","year":"2011","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.omtn.2025.102682_bib244","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat. Med."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:17:52Z","timestamp":1772896672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":244,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2162253125002367"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102682","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress and prospect of minicircle as a minimized non-viral DNA vector in gene therapy and regenerative medicine","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102682"}}